Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Aurinia Pharmaceuticals stock
Learn how to easily invest in Aurinia Pharmaceuticals stock.
Aurinia Pharmaceuticals is a biotechnology business based in the US. Aurinia Pharmaceuticals shares (AUPH) are listed on the NASDAQ and all prices are listed in US Dollars. Aurinia Pharmaceuticals employs 300 staff and has a trailing 12-month revenue of around $129 million.
How to buy Aurinia Pharmaceuticals stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – AUPH. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Commission-free trading
- Commission-free crypto
- No minimum account balance
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Aurinia Pharmaceuticals stock price (NASDAQ: AUPH)Use our graph to track the performance of AUPH stocks over time.
Aurinia Pharmaceuticals shares at a glance
|Latest market close||$9.21|
|52-week range||$4.07 - $20.48|
|50-day moving average||$5.68|
|200-day moving average||$8.41|
|Wall St. target price||$12.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.27|
Buy Aurinia Pharmaceuticals stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Aurinia Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Aurinia Pharmaceuticals price performance over time
|1 week (2023-01-20)||10.56%|
|1 month (2022-12-27)||124.09%|
|3 months (2022-10-27)||16.43%|
|6 months (2022-07-27)||7.34%|
|1 year (2022-01-27)||-37.13%|
|2 years (2021-01-27)||-42.62%|
|3 years (2020-01-27)||18.37|
|5 years (2018-01-26)||63.88%|
Aurinia Pharmaceuticals financials
|Revenue TTM||$129 million|
|Gross profit TTM||$-6,625,000|
|Return on assets TTM||-17.1%|
|Return on equity TTM||-32%|
|Market capitalisation||$1.2 billion|
TTM: trailing 12 months
Aurinia Pharmaceuticals share dividends
We're not expecting Aurinia Pharmaceuticals to pay a dividend over the next 12 months.
Have Aurinia Pharmaceuticals's shares ever split?
Aurinia Pharmaceuticals's shares were split on a 1:50 basis on 22 October 2013. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aurinia Pharmaceuticals shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for Aurinia Pharmaceuticals shares which in turn could have impacted Aurinia Pharmaceuticals's share price.
Aurinia Pharmaceuticals share price volatility
Over the last 12 months, Aurinia Pharmaceuticals's shares have ranged in value from as little as $4.07 up to $20.475. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aurinia Pharmaceuticals's is 0.8378. This would suggest that Aurinia Pharmaceuticals's shares are less volatile than average (for this exchange).
Aurinia Pharmaceuticals overview
Aurinia Pharmaceuticals Inc. , a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co. , Ltd. The company is headquartered in Victoria, Canada. .
Aurinia Pharmaceuticals in the news
Aurinia Announces PTAB Has Terminated Inter Partes Review
Aurinia Pharmaceuticals Announces Allowance of a New and Refined Method of Use Patent for LUPKYNIS® in the Treatment of Lupus Nephritis From the United States Patent and Trademark Office
Investors ignore increasing losses at Aurinia Pharmaceuticals (NASDAQ:AUPH) as stock jumps 21% this past week
Frequently asked questionsWhat percentage of Aurinia Pharmaceuticals is owned by insiders or institutions?
Currently 6.742% of Aurinia Pharmaceuticals shares are held by insiders and 41.937% by institutions. How many people work for Aurinia Pharmaceuticals?
Latest data suggests 300 work at Aurinia Pharmaceuticals. When does the fiscal year end for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals's fiscal year ends in December. Where is Aurinia Pharmaceuticals based?
Aurinia Pharmaceuticals's address is: 4464 Markham Street, Victoria, BC, Canada, V8Z 7X8 What is Aurinia Pharmaceuticals's ISIN number?
Aurinia Pharmaceuticals's international securities identification number is: CA05156V1022 What is Aurinia Pharmaceuticals's CUSIP number?
Aurinia Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 05156V102
More guides on Finder
How to buy TXO Energy (TXO) stock when it goes public
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock when it goes public
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert